|
|
|
| Clinical effect of Xiaoer Yanbian Granules in treatment of upper respiratory tract infection complicated with febrile convulsion |
| WU Qiong CHEN Fengyi YANG Cui |
| Department of Pediatrics, Yichang First People′s Hospital, Hubei Province, Yichang 443000, China |
|
|
|
Abstract Objective To investigate the clinical efficacy and safety of Xiaoer Yanbian Granules in treatment of upper respiratory tract infection complicated with febrile convulsion. Methods From January 2015 to January 2018, in Yichang First People's Hospital, 238 children with upper respiratory tract infection complicated with febrile convulsion were selected, according to random number table method, they were divided into control group and treatment group, with 119 cases in each group. The control group was treated with conventional therapy, the treatment group was treated with Xiaoer Yanbian Granules on the basis of conventional therapy, the two groups were treated for 3-7 d. The clinical efficacy of the two groups was evaluated and compared, the defervescence time, fading time of coughing, fading time of nasal obstruction and nasal discharge,the fading time of convulsion and the cases of convulsion recurrence in the two groups was recorded and compared, serum level of neuron-specific enolase (NSE) and S-100β protein were measured and compared between the two groups before and after treatment. The adverse reactions in the two groups were recorded and compared. Results The total effective rate of the treatment group was higher than the control group, the difference was statistically significant (P < 0.05). The defervescence time, the fading time of coughing, the fading time of nasal obstruction and nasal discharge, fading time of convulsion and the cases of convulsion recurrence in the treatment group were significantly less than the control group, the differences were statistically significant (P < 0.05). After treatment, the serum NSE, S-100β level of the two groups were significantly lower than before treatment, and these in the treatment group were significantly lower than the control group, the differences were statistically significant (P < 0.05). During the treatment, the incidence of adverse reactions in the treatment group was higher than the control group, but the difference was not statistically significant (P > 0.05). Conclusion Xiaoer Yanbian Granules is effective in the treatment of upper respiratory tract infection complicated with febrile convulsion. It can shorten the duration of clinical symptoms and improve the brain injury of children, it is safe and worthy of clinical application.
|
|
|
|
|
|
[1] 马树勋.小儿热性惊厥临床探讨[J].医药论坛杂志，2013， 34（10）：106-107.
[2] 温清芬，王芳，林亚芬.298例小儿首次热性惊厥发作的临床特征及其影响因素分析[J].中国妇幼保健，2017，32（9）：1933-1936.
[3] 陈瑞珊，海冬，王彩芳，等.小儿牛黄清心散治疗急性上呼吸道感染合并热性惊厥的疗效观察[J].世界最新医学信息文摘，2016，16（6）：110-114.
[4] 孙文静.小儿热性惊厥的表现及治疗[J].世界最新医学信息文摘，2015，15（45）：107.
[5] 刘国强，郝星霞，王继春.急性上呼吸道感染发生热性惊厥的危险因素分析及护理干预[J].内蒙古医科大学学报，2015，37（S1）：367-370.
[6] 李珊.小儿上呼吸道感染致高热惊厥的急救与治疗[J].临床和实验医学杂志，2011，10（13）：1035-1036.
[7] 赵慧萍，严红，闫血梅.小儿咽扁颗粒的质量控制[J].中草药，2001，32（12）：38-39.
[8] 闫焕，赵文静，常惟智.牛黄的药理作用及临床应用研究进展[J].中医药信息，2013，30（2）：114-116.
[9] 胡亚美，江载芳.诸福棠实用儿科学[M].7版.北京：人民卫生出版社，2005.
[10] 沈晓明，王卫平.儿科学[M].7版.北京：人民卫生出版，2013.
[11] 张永平，钟亮，徐锦华，等.小儿热性惊厥174例临床与复发因素分析[J].宁夏医学杂志，2013，35（2）：135-137.
[12] 林耘.小儿牛黄清心散治疗儿童急性上呼吸道感染合并热性惊厥40例疗效观察[J].航空航天医学杂志，2018， 29（6）：736-737.
[13] 赵瑞玲.门诊小儿上呼吸道感染导致热性惊厥的急救方法分析[J].黑龙江医药，2017，30（5）：1152-1153.
[14] 吴梅青，刘佳佳，戴艳群.小儿咽扁颗粒的提取工艺优化研究[J].现代中药研究与实践，2009，23（4）：44-46.
[15] 梁玉香，韩丹，洪岩斌.HPLC法测定小儿咽扁颗粒中绿原酸的含量[J].中国医药指南，2013，11（14）：481-482.
[16] 韩桂茹，张淑萍，安丽娜，等.HPLC法测定金银花及小儿咽扁颗粒中4种绿原酸[J].中成药，2013，35（3）：517-521.
[17] 刘倩，栗芬琴，栗得蕾.小儿咽扁颗粒中绿原酸含量的测定[J].中国民族民间医药，2010，19（16）：85.
[18] 董占军，韩桂茹，安丽娜，等.小儿咽扁颗粒质量控制方法的简化研究[J].河北中医，2011，33（8）：1224-1283.
[19] 阮宏鹏，王显于，李振华.小儿咽扁颗粒佐治疱疹性咽峡炎疗效观察[J].现代中西医结合杂志，2011，20（23）：2933-2934.
[20] 瞿秋兰，谢艳.小儿咽扁颗粒治疗儿童急性化脓性扁桃体炎疗效观察[J].现代中西医结合杂志，2007，16（25）：3677.
[21] 漆敏，程春瑞.S-100蛋白和神经元特异性烯醇化酶对昏迷脑损伤住院死亡的预测价值[J].重庆医学，2012， 41（25）：2600.
[22] 陆睿，邹璐檐，吉学元，等.小儿牛黄清心散治疗上呼吸道感染合并热性惊厥36例疗效观察[J].中国中西医结合儿科学，2013，5（6）：547-548. |
|
|
|
